• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一系列天冬氨酸转氨甲酰酶抑制剂的合成与生物活性:N-取代天冬氨酸二乙酯和N-取代-3-氧代-1,4-哌嗪-2-乙酸酯

Synthesis and biological activity of a series of aspartate transcarbamoylase inhibitors: N-substituted diethyl aspartates and N-substituted-3-oxo-1,4-piperazine-2-acetic acid esters.

作者信息

Dutta P L, Foye W O

机构信息

Samuel M. Best Research Laboratory, Massachusetts College of Pharmacy and Allied Health Sciences, Boston, MA 02115.

出版信息

J Pharm Sci. 1990 May;79(5):447-52. doi: 10.1002/jps.2600790519.

DOI:10.1002/jps.2600790519
PMID:2352167
Abstract

Series of N-substituted diethyl aspartates and N-substituted-3-oxo-1,4-piperazine-2-acetic acid esters were synthesized as potential inhibitors of aspartate transcarbamoylase. The aspartates were obtained by addition of substituted alkyl amines to diethyl maleate, or conversion of the hydroxy ethyl amino adduct to other functions. The 3-oxo-1,4-piperazine-2-acetic acid esters were prepared by addition of ethylene diamine to diethyl maleate, followed by cyclization. Addition of 1,2-diamino-2-methylpropane gave the corresponding 5,5-dimethyl-3-oxo-1,4-piperazine-2-acetic acid ester. N-Acyl derivatives in each series were obtained using the bromoacyl chlorides. A majority of the compounds in each series showed antimicrobial activity against five representative microorganisms, as well as significant activity against aspartate transcarbamoylase. Four of the compounds were found to have significant specificity against several tumor cell lines. A distance of two carbons between N and a reactive function was found to give the best activity for either antimicrobial, antienzyme, or tumor cell specificity activities, in either the open chain aspartates or cyclic piperazines. Little difference in anti-enzyme activity was found between the aspartates and piperazines, but introduction of the planar phenyl substituents lowered inhibitory activity.

摘要

合成了一系列N-取代天冬氨酸二乙酯和N-取代-3-氧代-1,4-哌嗪-2-乙酸酯,作为天冬氨酸转氨甲酰酶的潜在抑制剂。通过将取代的烷基胺加入马来酸二乙酯中,或将羟乙基氨基加合物转化为其他官能团来获得天冬氨酸酯。3-氧代-1,4-哌嗪-2-乙酸酯是通过将乙二胺加入马来酸二乙酯中,然后环化制备的。加入1,2-二氨基-2-甲基丙烷得到相应的5,5-二甲基-3-氧代-1,4-哌嗪-2-乙酸酯。使用溴代酰氯获得每个系列中的N-酰基衍生物。每个系列中的大多数化合物对五种代表性微生物显示出抗菌活性,以及对天冬氨酸转氨甲酰酶具有显著活性。发现其中四种化合物对几种肿瘤细胞系具有显著特异性。发现在N与反应性功能之间相隔两个碳原子时,对于开链天冬氨酸酯或环状哌嗪中的抗菌、抗酶或肿瘤细胞特异性活性均能产生最佳活性。在天冬氨酸酯和哌嗪之间未发现抗酶活性有太大差异,但引入平面苯基取代基会降低抑制活性。

相似文献

1
Synthesis and biological activity of a series of aspartate transcarbamoylase inhibitors: N-substituted diethyl aspartates and N-substituted-3-oxo-1,4-piperazine-2-acetic acid esters.一系列天冬氨酸转氨甲酰酶抑制剂的合成与生物活性:N-取代天冬氨酸二乙酯和N-取代-3-氧代-1,4-哌嗪-2-乙酸酯
J Pharm Sci. 1990 May;79(5):447-52. doi: 10.1002/jps.2600790519.
2
Design, synthesis, and bioactivity of novel inhibitors of E. coli aspartate transcarbamoylase.新型大肠杆菌天冬氨酸转氨甲酰酶抑制剂的设计、合成及生物活性
Bioorg Med Chem Lett. 2007 Apr 1;17(7):2086-90. doi: 10.1016/j.bmcl.2006.12.050. Epub 2006 Dec 21.
3
Phosphorus-containing inhibitors of aspartate transcarbamoylase from Escherichia coli.
FEBS Lett. 1990 Jan 29;260(2):206-8. doi: 10.1016/0014-5793(90)80104-q.
4
Design and synthesis of new transition-state analogue inhibitors of aspartate transcarbamylase.
J Med Chem. 1985 Nov;28(11):1668-73. doi: 10.1021/jm00149a022.
5
Efficient synthesis of fluorothiosparfosic acid analogues with potential antitumoral activity.
Bioorg Med Chem. 2005 Aug 15;13(16):4921-8. doi: 10.1016/j.bmc.2005.05.026.
6
Synthesis and in vitro evaluation of aspartate transcarbamoylase inhibitors.天冬氨酸转氨甲酰酶抑制剂的合成及体外评价。
Bioorg Med Chem. 2009 Nov 15;17(22):7680-9. doi: 10.1016/j.bmc.2009.09.045. Epub 2009 Sep 30.
7
Enzymatic assay for the antitumor agent-N-(phosphonacetyl)-L-aspartic acid (PALA).抗肿瘤药物N-(膦酰乙酰基)-L-天冬氨酸(PALA)的酶活性测定
Cancer Treat Rep. 1979 Jan;63(1):85-8.
8
Ligand-promoted strengthening of interchain bonding domains in catalytic subunits of aspartate transcarbamoylase.
J Biol Chem. 1982 Oct 25;257(20):12214-8.
9
Structure and Functional Characterization of Human Aspartate Transcarbamoylase, the Target of the Anti-tumoral Drug PALA.人天冬氨酸转氨甲酰酶的结构与功能特性,抗瘤药物N-(磷乙酰基)-L-天冬氨酸的作用靶点
Structure. 2016 Jul 6;24(7):1081-94. doi: 10.1016/j.str.2016.05.001. Epub 2016 Jun 2.
10
Kinetic parameters of aspartate transcarbamylase in human normal and tumoral cell lines.人正常及肿瘤细胞系中天冬氨酸转氨甲酰酶的动力学参数
Cancer Res. 1983 May;43(5):2277-82.

引用本文的文献

1
The stereochemistry of amide side chains containing carboxyl groups influences water exchange rates in EuDOTA-tetraamide complexes.含羧基酰胺侧链的立体化学影响 EuDOTA-四酰胺配合物中的水交换速率。
J Biol Inorg Chem. 2014 Feb;19(2):161-71. doi: 10.1007/s00775-013-1031-3. Epub 2013 Aug 27.
2
Synthesis and in vitro evaluation of aspartate transcarbamoylase inhibitors.天冬氨酸转氨甲酰酶抑制剂的合成及体外评价。
Bioorg Med Chem. 2009 Nov 15;17(22):7680-9. doi: 10.1016/j.bmc.2009.09.045. Epub 2009 Sep 30.
3
Submicromolar phosphinic inhibitors of Escherichia coli aspartate transcarbamoylase.
亚微摩尔浓度的大肠埃希菌天冬氨酸转氨甲酰酶的膦酸抑制剂。
Bioorg Med Chem Lett. 2009 Feb 1;19(3):900-2. doi: 10.1016/j.bmcl.2008.11.115. Epub 2008 Dec 6.